172 related articles for article (PubMed ID: 17655271)
21. GPR30 Mediates the Fast Effect of Estrogen on Mouse Blastocyst and its Role in Implantation.
Yu LL; Qu T; Zhang SM; Yuan DZ; Xu Q; Zhang JH; He YP; Yue LM
Reprod Sci; 2015 Oct; 22(10):1312-20. PubMed ID: 25820689
[TBL] [Abstract][Full Text] [Related]
22. Attenuation of CXCR4 responses by CCL18 in acute lymphocytic leukemia B cells.
Catusse J; Wollner S; Leick M; Schröttner P; Schraufstätter I; Burger M
J Cell Physiol; 2010 Nov; 225(3):792-800. PubMed ID: 20568229
[TBL] [Abstract][Full Text] [Related]
23. GPR30: A G protein-coupled receptor for estrogen.
Prossnitz ER; Arterburn JB; Sklar LA
Mol Cell Endocrinol; 2007 Feb; 265-266():138-42. PubMed ID: 17222505
[TBL] [Abstract][Full Text] [Related]
24. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30.
Ramesh C; Nayak TK; Burai R; Dennis MK; Hathaway HJ; Sklar LA; Prossnitz ER; Arterburn JB
J Med Chem; 2010 Feb; 53(3):1004-14. PubMed ID: 20041667
[TBL] [Abstract][Full Text] [Related]
26. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
27. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
28. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.
Prossnitz ER; Arterburn JB; Smith HO; Oprea TI; Sklar LA; Hathaway HJ
Annu Rev Physiol; 2008; 70():165-90. PubMed ID: 18271749
[TBL] [Abstract][Full Text] [Related]
29. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption.
Thomas P; Dong J
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):175-9. PubMed ID: 17088055
[TBL] [Abstract][Full Text] [Related]
30. G protein-coupled receptor 30 down-regulates cofactor expression and interferes with the transcriptional activity of glucocorticoid.
Ylikomi T; Vienonen A; Ahola TM
Eur J Biochem; 2004 Nov; 271(21):4159-68. PubMed ID: 15511221
[TBL] [Abstract][Full Text] [Related]
31. Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.
Barton M; Filardo EJ; Lolait SJ; Thomas P; Maggiolini M; Prossnitz ER
J Steroid Biochem Mol Biol; 2018 Feb; 176():4-15. PubMed ID: 28347854
[TBL] [Abstract][Full Text] [Related]
32. Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111in-labeled nonsteroidal imaging agents.
Nayak TK; Dennis MK; Ramesh C; Burai R; Atcher RW; Sklar LA; Norenberg JP; Hathaway HJ; Arterburn JB; Prossnitz ER
ACS Chem Biol; 2010 Jul; 5(7):681-90. PubMed ID: 20486699
[TBL] [Abstract][Full Text] [Related]
33. Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
Chen Y; Li Z; He Y; Shang D; Pan J; Wang H; Chen H; Zhu Z; Wan L; Wang X
Toxicol Appl Pharmacol; 2014 Mar; 275(2):176-81. PubMed ID: 24440569
[TBL] [Abstract][Full Text] [Related]
34. Analysis of G-Protein Coupled Receptor 30 (GPR30) on Endothelial Inflammation.
Chakrabarti S; Davidge ST
Methods Mol Biol; 2016; 1366():503-516. PubMed ID: 26585160
[TBL] [Abstract][Full Text] [Related]
35. Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells.
Henic E; Noskova V; Høyer-Hansen G; Hansson S; Casslén B
Int J Gynecol Cancer; 2009 Feb; 19(2):214-22. PubMed ID: 19395996
[TBL] [Abstract][Full Text] [Related]
36. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
[TBL] [Abstract][Full Text] [Related]
37. Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression.
Akimoto T; Takasawa A; Takasawa K; Aoyama T; Murata M; Osanai M; Saito T; Sawada N
Neoplasia; 2018 Oct; 20(10):1083-1093. PubMed ID: 30227306
[TBL] [Abstract][Full Text] [Related]
38. Is the membrane estrogen receptor, GPER1, a promiscuous receptor that modulates nuclear estrogen receptor-mediated functions in the brain?
Vajaria R; Vasudevan N
Horm Behav; 2018 Aug; 104():165-172. PubMed ID: 29964007
[TBL] [Abstract][Full Text] [Related]
39. Expression and functional roles of estrogen receptor GPR30 in human intervertebral disc.
Wei A; Shen B; Williams LA; Bhargav D; Yan F; Chong BH; Diwan AD
J Steroid Biochem Mol Biol; 2016 Apr; 158():46-55. PubMed ID: 26815911
[TBL] [Abstract][Full Text] [Related]
40. 17-Beta-estradiol inhibits transforming growth factor-beta signaling and function in breast cancer cells via activation of extracellular signal-regulated kinase through the G protein-coupled receptor 30.
Kleuser B; Malek D; Gust R; Pertz HH; Potteck H
Mol Pharmacol; 2008 Dec; 74(6):1533-43. PubMed ID: 18768737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
